Frankenstein Variant: Symptoms, Contagion & What We Know
- Dubbed "Frankenstein" due to its composite nature - originating from multiple COVID-19 strains - the XFG variant, also known as stratus, is a newly identified form...
- Antoine Flahault, professor of public health at the University of Geneva, confirmed to actu.fr that this variant is particularly contagious.
- The XFG variant is a primary driver of the recent resurgence of COVID-19 in France.
“`html
XFG Variant (Stratus): The “Frankenstein” COVID-19 Strain Resurging in France
Table of Contents
- News
What is the XFG Variant?
Dubbed “Frankenstein” due to its composite nature – originating from multiple COVID-19 strains – the XFG variant, also known as stratus, is a newly identified form of the virus gaining prominence. It’s not named for physical resemblance to Mary Shelley’s creature, but rather for its genetic origins.
Antoine Flahault, professor of public health at the University of Geneva, confirmed to actu.fr that this variant is particularly contagious. Its ability to spread even during the summer months is notable,with increased media attention beginning earlier in the summer season.
COVID-19 Resurgence in France: The Role of XFG
The XFG variant is a primary driver of the recent resurgence of COVID-19 in France. While currently appearing less severe than previous waves, health officials anticipate continued circulation throughout the fall and into early winter.
Key to the variant’s increased transmissibility are mutations in the Spike protein, specifically at amino acid positions 478 and 487. These mutations enhance the virus’s ability to evade existing antibody defenses.
Understanding the Mutations and Immune Evasion
The mutations in the spike protein are critical. The Spike protein is the part of the virus that binds to human cells, initiating infection. Changes to this protein can alter how effectively antibodies recognise and neutralize the virus. Mutations at positions 478 and 487 specifically impact the antibody binding site, reducing the effectiveness of immunity gained from prior infection or vaccination.
Further research is ongoing to determine the precise degree of immune evasion conferred by these mutations and to assess the potential impact on vaccine effectiveness. Preliminary data suggests that while vaccines may not prevent infection entirely, thay continue to offer notable protection against severe illness, hospitalization, and death.